ß-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases-Historical Aspects and Nowadays Understanding.
Int J Mol Sci
; 24(5)2023 Feb 28.
Article
em En
| MEDLINE
| ID: mdl-36902129
ABSTRACT
ß-adrenoreceptors (ARs) are members of the superfamily of G-protein-coupled receptors (GPCRs), and are activated by catecholamines, such as epinephrine and norepinephrine. Three subtypes of ß-ARs (ß1, ß2, and ß3) have been identified with different distributions among ocular tissues. Importantly, ß-ARs are an established target in the treatment of glaucoma. Moreover, ß-adrenergic signaling has been associated with the development and progression of various tumor types. Hence, ß-ARs are a potential therapeutic target for ocular neoplasms, such as ocular hemangioma and uveal melanoma. This review aims to discuss the expression and function of individual ß-AR subtypes in ocular structures, as well as their role in the treatment of ocular diseases, including ocular tumors.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oftalmopatias
/
Melanoma
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article